1. You can also request for sample page of above
mention reports on sample@aarkstore.com
2. Pages : 41
PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $
6000 |
20% Off on above 1000$ Reports
25% off on purchase of 2 reports and 30% on purchase of
3 or more reports.
Discount till 31st Dec. 2012.
3. Summary
Global Markets Direct’s, Pheochromocytoma - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for
Pheochromocytoma, complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players involved in
the therapeutic development for Pheochromocytoma. Pheochromocytoma -
Pipeline Review, Half Year is built using data and information sourced from
Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources,
put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Pheochromocytoma.
- A review of the Pheochromocytoma products under development by
companies and universities/research institutes based on information derived
from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Pheochromocytoma.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table of Contents :
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Pheochromocytoma Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Pheochromocytoma 7
Pheochromocytoma Therapeutics under Development by Companies 9
Pheochromocytoma Therapeutics under Investigation by
Universities/Institutes 10
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pheochromocytoma Therapeutics – Products under Development by
Companies 14
Pheochromocytoma Therapeutics – Products under Investigation by
Universities/Institutes 15………………
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1
